Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ib Study Evaluating Safety and Efficacy of PRGN-3005 UltraCAR-T® (Autologous CAR T Cells) in Advanced Stage Platinum Resistant Ovarian Cancer Patients

NCT03907527 is registered in ClinicalTrials.gov with Precigen, Inc as lead sponsor.

NCT NCT03907527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03907527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ib Study Evaluating Safety and Efficacy of PRGN-3005 UltraCAR-T® (Autologous CAR T Cells) in Advanced Stage Platinum Resistant Ovarian Cancer Patients
Lead sponsor
Precigen, Inc
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 30, 2019
Completion date
November 15, 2028
Enrollment
71 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

platinum-resistant fallopian tube carcinoma, platinum-resistant ovarian carcinoma, platinum-resistant primary peritoneal carcinoma, recurrent fallopian tube carcinoma, recurrent ovarian carcinoma, recurrent primary peritoneal carcinoma, refractory fallopian tube carcinoma, refractory ovarian carcinoma, refractory primary peritoneal carcinoma, stage iii fallopian tube cancer ajcc v8, stage iii ovarian cancer ajcc v8, stage iii primary peritoneal cancer ajcc v8, stage iiia fallopian tube cancer ajcc v8, stage iiia ovarian cancer ajcc v8, stage iiia primary peritoneal cancer ajcc v8, stage iiia1 fallopian tube cancer ajcc v8, stage iiia1 ovarian cancer ajcc v8, stage iiia2 fallopian tube cancer ajcc v8, stage iiia2 ovarian cancer ajcc v8, stage iiib fallopian tube cancer ajcc v8, stage iiib ovarian cancer ajcc v8, stage iiib primary peritoneal cancer ajcc v8, stage iiic fallopian tube cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic primary peritoneal cancer ajcc v8, stage iv fallopian tube cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv primary peritoneal cancer ajcc v8, stage iva fallopian tube cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva primary peritoneal cancer ajcc v8, stage ivb fallopian tube cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb primary peritoneal cancer ajcc v8